The Covered Calls for Dummies Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Covered Calls for Dummies Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: alanrs who wrote (4616)	12/17/2006 9:42:31 PM
From: alanrs	of 5205

I did a buy/write on NFLD last week, buying the stock at an average price of $15.29 and selling the Jan 10 call at an average of $6.74. The stock closed at $14.79 Friday, and has traded in a range of $8-18 the last 52 weeks. I've owned a few shares for almost 2 years. They have a blood substitute in phase three testing. The test parameters are a little different from most with the product being used in emergency situations rather than on a fixed group of patients with a specific disease. If you know of this company and/or it's product, there are a few combinations that look attractive, depending on ones assessment of their possibilities. Not a recommendation to do anything one way or another. ARS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next